Breaking News

Close

Sellas Life Sciences Group Inc (SLS)

Add to/Remove from Watchlist Add to Watchlist

1.33 -0.01 -0.75%

31/12 - Closed. Currency in USD ( Disclaimer )

After Hours

1.34

0.00

0.38%

19:59:53 - Real-time Data

Type: Equity

Market: United States

Volume: 804,914
Bid/Ask: 0.00 / 0.00
Day's Range: 1.27 - 1.37

Sellas Life Sciences Group Inc Company Profile

Get an in-depth profile of Sellas Life Sciences Group Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

17

Equity Type

ORD

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company’s lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase 3 clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009, a highly selective small molecule CDK9 inhibitor, currently under Phase 1 clinical trials. The company is headquartered in New York, New York.

Contact Information

Address Times Square Tower Suite 2503
7 Times Square New York, 10036
United States

Phone 646 200 5278

Fax -

Web www.sellaslifesciences.com

Top Executives

Name	Age	Since	Title
Robert L. Van Nostrand	64	2017	Independent Director
Jeffrey S. Weber	-	2016	Chairman of Scientific Advisory Board
Angelos M. Stergiou	45	2012	Founder, President, CEO & Director
John W. Varian	61	2017	Independent Director
Jane Wasman	65	2017	Independent Chairman
Larry W. Kwak	-	2015	Member of Scientific Advisory Board
David A. Scheinberg	68	2015	Independent Director
Javier Pinilla-Ibarz	-	2016	Member of Scientific Advisory Board
Guenther Koehne	-	-	Member of Scientific Advisory Board
Sattva S. Neelapu	-	-	Member of Scientific Advisory Board
Katherine Bach Kalin	61	2022	Independent Director

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

SLS Comments

Write your thoughts about Sellas Life Sciences Group Inc

Are you sure you want to delete this chart?

Post also to:

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Antoine Neaime Nov 15, 2022 11:16AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

will go up now to 2.4🚀🚀🚀

1 1

Mr Worldwide Jul 21, 2021 2:56PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

gains

0 0

May Fong Jennifer Chong Jul 21, 2021 2:56PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

cannot see it on its chart

0 0

Zoran Labus Jun 24, 2021 10:37AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

To clarify, this is a report for alignant pleural mesothelioma (MPM). which is in the first stageThe report for Acute Myeloid Leukemia (AML) which is in the third phase is coming out by the end of June. you have to wait, for now everything is ok

4 1

Zoran Labus Jun 24, 2021 9:27AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Updated Data Show Median Overall Survival of 35.4 Weeks in Patients Treated With Combination Therapy for at Least One Month – Median Overall Survival in Relapse/Refractory Patients with Standard of Care is Approximately 28 weeksNew and Updated Clinical and Translational Data Expected by End of Q4 2021NEW YORK, June 24, 2021 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ("SELLAS" or the “Company”), a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies for a broad range of indications, today announced encouraging updated clinical data from a Phase 1 investigator-sponsored clinical trial of its lead clinical candidate, galinpepimut-S (GPS), combined with the checkpoint inhibitor nivolumab (Opdivo®) in patients with macroscopic (measurable) deposits of malignant pleural mesothelioma (MPM).

2 0

Zoran Labus Jun 24, 2021 8:58AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

very good test results

2 0

Nonoy Jaca Jun 23, 2021 11:45AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

👍👍

4 0

Zoran Labus Jun 23, 2021 9:23AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

soon going to 30-50

2 0

Exar Kun Jun 22, 2021 9:31AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Russel microcap index add.... Good...

1 0

Tom Pokos Jun 14, 2021 5:53PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Been in this from $2 21000shares I believe life changer

1 0

andrew mccorkle Jun 08, 2021 10:46AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

oll

0 0

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="206115488">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="206115488" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="206115488" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="206115488">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="213089076">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="213089076" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="213089076" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="213089076">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
		</div>
    </div>
			</div>
			<div id="show-more-comments">
				<a class="showMoreComments block">
					<span class="arial_12 showArrowafter">Show more comments (<span class="js-amount"></span>)</span>
				</a>
			</div>
			<div id="show-more-replies">
				<a class="showMoreReplies block">
					<span class="arial_12 showArrowafter">Show more replies (<span class="js-amount"></span>)</span>
				</a>
			</div>

Are you sure you want to delete this chart?

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

	US 30	37,693.5	-41.6	-0.11%
	US 500	5,056.9	-4.9	-0.10%
	Dow Jones	37,735.11	-248.13	-0.65%
	S&P 500	5,061.82	-61.59	-1.20%
	Nasdaq	15,885.02	-290.08	-1.79%
	S&P 500 VIX	19.23	+0.00	+0.00%
	Dollar Index	106.085	+0.087	+0.08%

	Crude Oil WTI	85.97	+0.56	+0.66%
	Brent Oil	90.68	+0.58	+0.64%
	Natural Gas	1.690	+0.002	+0.12%
	Gold	2,403.50	+20.50	+0.86%
	Silver	28.915	+0.198	+0.69%
	Copper	4.3632	-0.0148	-0.34%
	US Soybeans	1,160.00	+1.50	+0.13%

	U.S. 10Y	4.612	-0.017	-0.37%
	U.S. 30Y	4.728	-0.012	-0.25%
	U.S. 5Y	4.633	-0.012	-0.26%
	U.S. 3M	5.424	+0.036	+0.67%
	US 10Y T-Note	108.00	+0.11	+0.10%
	Euro Bund	131.97	+0.06	+0.05%
	10-2 Yield Spread	-31.72	+6.18	+-16.31%

	Apple	172.69	-3.86	-2.19%
	Alphabet A	154.86	-2.87	-1.82%
	Tesla	161.48	-9.57	-5.59%
	Amazon.com	183.62	-2.51	-1.35%
	Netflix	607.15	-15.68	-2.52%
	Meta Platforms	500.23	-11.67	-2.28%
	Bank of America	35.95	+0.15	+0.43%

Recent Quotes

	Name	Price	Chg.	Chg. %
	SLS	1.33	-0.01	-0.75%

	Name	Last	Chg. %	Vol.
	TSLA	161.48	-5.59%	96.36M
	AAPL	172.69	-2.19%	69.50M
	AMD	160.32	-1.81%	60.16M
	AMZN	183.62	-1.35%	45.05M
	NVDA	860.01	-2.48%	43.31M
	MSFT	413.64	-1.96%	18.66M
	BRKa	604,580	-0.58%	17.12K

	Name	Last	Chg. %	Vol.
	MTB	140.88	+4.70%	2.92M
	GS	400.75	+2.89%	6.10M
	VLTO	89.86	+2.85%	1.82M
	CNC	72.72	+2.81%	5.50M
	CAH	107.04	+1.85%	1.84M
	SCHW	71.26	+1.76%	13.29M
	INTC	36.31	+1.74%	44.52M

	Name	Last	Chg. %	Vol.
	CRM	272.75	-7.33%	17.70M
	TEAM	191.84	-7.11%	2.08M
	TTD	80.99	-6.23%	3.74M
	TSLA	161.48	-5.59%	96.36M
	GL	55.82	-5.53%	6.56M
	ILMN	121.16	-4.65%	1.54M
	NOW	735.53	-4.32%	1.14M